[1]
Gómez, X. et al. 2017. Tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an unattended need. Revista Peruana de Medicina Experimental y Salud Pública. 34, 2 (Jun. 2017), 349–50. DOI:https://doi.org/10.17843/rpmesp.2017.342.2690.